Compounds Clinics Methodology About

Browse Database

Hikma Pharmaceuticals USA Inc.

FDA 503B outsourcing facility

Cherry Hill, New Jersey

Verified June 2, 2026 against the FDA 503B list.

PeptideGrids

Not medical advice. PeptideGrids provides evidence summaries for informational purposes only. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendation. Always consult a licensed healthcare provider before starting any medication or supplement.

FTC disclosure: We never link to peptide vendors, research-chemical suppliers, or gray-market sources. Directory listings are not paid placements. We may earn affiliate fees if you click through to FDA-approved prescription services, clearly labeled where applicable.

Independent and not affiliated with or endorsed by the FDA, NIH, or PubMed.

Database

GLP-1 Agents Therapeutic Peptides Clinic Directory Federal Compounding Status Evidence Grades A to D

Resources

Methodology Data Sources Medical Disclaimer FDA Action Tracker Research Compare About PeptideGrids Privacy

Legal

Terms of Use Affiliate Disclosure Editorial & Grading Policy Corrections & Takedown Contact

© PeptideGrids. Data sources cited on each page.

Part of the Grids directory family: PadelGrids

We use analytics to improve this site. You can decline without losing access to any content. Privacy policy.